Apogee Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
APGE
CUSIP
03770N101
Type
Equity
Class
COM
Num filings
310
Total reported value, excl. options
$8.97 B
Manager Report Date Value ($000) Shares Option Type